Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges

ConditionHyponatremia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Cologne

About this trial

Hyponatremia is the most common electrolyte disorder of all and can be observed in more than 30% of all patients in hospitals. Osmotic homeostasis of body fluids is essential for survival of all living creatures. It is widely accepted that extra- and intracellular osmolalities are in equilibrium at all times and thus, changes in the extracellular osmolality will lead to either shrinkage or swelling of cells which can be detrimental. In severe cases, it can lead to swelling of the brain and death. Even in less dramatic scenarios, symptoms such as epileptic seizures, headaches, depression and dizziness exist, leading to an increased risk of fractures, hospital admissions and a considerable burden for affected patients.

As short-term defense against osmotic stress, each individual cell is capable of actively externalizing or internalizing osmotically active solutes which restores normal or near-normal cell volume at the expense of an altered milieu interior. Obviously, there must be limitations to this strategy if intracellular integrity is meant to be kept stable. It has therefore been postulated that, apart from this cell-immanent mechanism, extracellular and intracellular electrolyte stores could assist in buffering osmotic imbalances.

The Edelman formula states that extracellular sodium is determined by the total amount of exchangeable body sodium (the major extracellular cation) plus potassium (the major intracellular cation) divided by total body water. Several studies have shown, that it only partially explains the changes in patients outside the osmotic equilibrium.

To better understand these physiological responses might not only promote the researcher's insight into the most basic cellular self-defense systems by measuring and comparing extra- and intracellular electrolyte concentrations with estimated changes in a patient that will be intravenously challenged with either water or sodium chloride 3%.

The evolution over time of extra- and intracellular sodium and other electrolytes will be assessed quantitatively in patients with impaired renal function after water or sodium chloride (NaCl) administration.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients ≥18 years

Requirement of renal replacement therapy due to surgical (i.e., nephrectomy) or non-surgical (chronic kidney disease) reason

Stable hemodialysis treatment for at least 3 months

Urine output <100ml in 24 hours

Disqualifiers

Peritoneal dialysis patients

Signs of volume expansion or contraction

Congestive heart failure (NYHA ≥2)

acute illness (infection, congestive heart failure, liver cirrhosis, etc.) requiring hospital admission

Trial design

Design model

Parallel

Treatments tested in this trial

  • Water administration

    Other intervention

    Intravenous administration of water (Aqua ad injectabilia) until a decrease of plasma sodium of 5 to 8 mmol/l has been achieved

  • NaCl-Administration

    Other intervention

    Intravenous administration of NaCl 3% until an increase of plasma sodium of 5 to 8 mmol/l has been achieved

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Water-GroupExperimental treatment 1 intervention
Group B: NaCl-GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

acute changes of extracellular osmolality

The primary aim is to compare the actual acute change of extracellular sodium with the estimated change of extracellular sodium in response to an intravenous challenge with either water or sodium. Precise evaluation of the validity of the concept of Edelman in acute changes of extracellular osmolality

Time frame
300 minutes after infusion

Secondary outcomes

1

change of extracellular electrolyte concentrations

extracellular electrolyte concentrations in response to an intravenous challenge with either water or sodium.

Time frame
300 minutes after infusion
2

change of intracellular electrolyte concentrations

intracellular (red blood cells/white blood cells) electrolyte concentrations in response to an intravenous challenge with either water or sodium.

Time frame
300 minutes after infusion
3

change of osmolality

change of osmolality in response to an intravenous challenge with either water or sodium

Time frame
300 minutes after infusion
4

change of cell volume

cell volume (red blood cells) in response to an intravenous challenge with either water or sodium

Time frame
300 minutes after infusion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.